BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAD4. A total of 35 filers reported holding BRIDGEBIO PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $45,000 | -98.4% | 60,000 | -98.7% | 0.00% | -98.3% |
| Q2 2023 | $2,773,807 | -67.3% | 4,482,000 | -65.8% | 0.12% | -53.8% |
| Q1 2023 | $8,493,253 | +23.4% | 13,120,000 | -27.2% | 0.26% | +46.9% |
| Q4 2022 | $6,881,388 | -13.9% | 18,020,000 | 0.0% | 0.18% | +0.6% |
| Q3 2022 | $7,995,000 | +4.7% | 18,020,000 | 0.0% | 0.18% | +2.3% |
| Q2 2022 | $7,635,000 | -9.5% | 18,020,000 | 0.0% | 0.17% | -21.8% |
| Q1 2022 | $8,433,000 | – | 18,020,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Diameter Capital Partners LP | 71,757,000 | $44,221,686 | 4.15% |
| Context Capital Management, LLC | 33,683 | $20,846 | 1.88% |
| INHERENT GROUP, LP | 9,000,000 | $5,587,173 | 1.54% |
| BRAIDWELL LP | 62,294,000 | $38,552,328 | 1.26% |
| Aequim Alternative Investments LP | 30,000,000 | $18,566,312 | 0.70% |
| DeepCurrents Investment Group LLC | 22,355,000 | $13,838,372 | 0.55% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 5,500,000 | $3,408,592 | 0.48% |
| ARISTEIA CAPITAL, L.L.C. | 30,280,000 | $18,739,598 | 0.42% |
| Weiss Asset Management LP | 4,500,000 | $2,773,209 | 0.21% |
| Orbimed Advisors | 15,000,000 | $9,265,350 | 0.17% |